{"entity":{"id":"nct02814968","kind":"trial","name":"PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide","aka":[],"tldr":"A phase 2 trial of Whole-body MRI in Prostate cancer, run by The European Uro-Oncology Group, completed.","summary":"PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide is a phase 2 interventional study registered as NCT02814968 by The European Uro-Oncology Group, with 66 participants recorded, started 2015-02 and reaching its primary completion in 2020-06. Interventions recorded: Enzalutamide, 18-FDG PET/CT, Whole body MRI, Bone scan. Conditions recorded: Prostate Cancer Metastatic.\n\nLinked to the technology Whole-body MRI because the registry names it (\"whole body mri\") among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT02814968","url":"https://clinicaltrials.gov/study/NCT02814968"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate"],"sections":[],"technologies":["whole-body-mri"],"targets":[],"drugs":["enzalutamide"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT02814968","phase":"2","setting":"A Phase 2, Open-label, Single-arm, Efficacy and Imaging Study of Oral Enzalutamide in Chemo-Naïve Patients With Progressive Prostate Cancer Who Have Failed Androgen Deprivation Therapy (Castration-resistant Prostate Cancer Patients)","sponsor":"The European Uro-Oncology Group","participation":[{"nct":"NCT02814968","source":"https://clinicaltrials.gov/study/NCT02814968","fetchedAt":"2026-10-07T16:52:51.872Z","studySha256":"92bc723451dc2d890fe195f87b6fb0e9c308c74dac5796b0dbd0b7532d9ffc09","overallStatus":"COMPLETED","lastUpdatePosted":"2022-04-14","leadSponsor":"The European Uro-Oncology Group","collaboratorCount":1,"minimumAge":"18 Years","sex":"MALE","healthyVolunteers":false,"hasEligibility":true,"enrolment":66,"enrolmentType":"ACTUAL","siteCount":1,"recruitingSiteCount":0,"countries":["Netherlands"]}],"started":"2015-02","enrolled":66,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct02814968/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"technology":[{"id":"whole-body-mri","kind":"technology","name":"Whole-body MRI","route":"/technologies/whole-body-mri/"}],"drug":[{"id":"enzalutamide","kind":"drug","name":"Enzalutamide","route":"/drugs/enzalutamide/"}]}}